NAVIGATION

Centers for Disease Control and Prevention



Autism Rate Continues To Rise: One in 54 Children in the U.S. Has Autism

04/2/20


Randolph, Mass. – As we mark World Autism Awareness Day 2020, a new estimate released by the Centers for Disease Control and Prevention (CDC) reveals that one in 54 U.S. children now has an autism spectrum disorder (ASD); two years ago, that figure was one in 59.

The updated numbers, published in the CDC’s Morbidity and Mortality Weekly Report, are based on data collected in 2016 from health and educational records of 8-year-olds living in 11 communities across America. Boys continue to be four times more likely to be diagnosed with ASD than girls, which makes the prevalence in boys one in 37, while the prevalence in girls is one in 151.

The sheer volume these data represent – at least one million U.S. boys and girls have autism, not to mention the rapidly growing number of adults with autism – is staggering.

Important findings in the recent report include the fact that more children are being evaluated for ASD, and at younger ages. Additionally, for the first time, the prevalence in black and white children is the same. This suggests that we are doing a better job across the country identifying children in some historically under-reached communities. 

However, the report also noted that, “Although no overall difference in ASD prevalence between black and white children aged 8 years was observed, the disparities for black children persisted in early evaluation and diagnosis of ASD. Hispanic children also continue to be identified as having ASD less frequently than white or black children.” [Read the report.

The call to action is clear. We must redouble our efforts to educate families and practitioners about autism’s early warning signs and diagnose children at a younger age. The earlier a child is diagnosed, the better the long-term outcome. Research shows that early diagnosis and intervention during the first years of a child’s life can significantly impact his or her long-term prognosis, particularly in the areas of language and social behavior.

We must also make information about the most effective evidence-based treatment for autism universally available, and create easier, faster, and more affordable access to that treatment for every child and family that needs it, across all communities, ethnicities, and socio-economic groups.

“Although we, like everyone else in the U.S., are dealing with the incredible challenges that have accompanied the COVID-19 crisis,” says May Institute President and CEO Lauren C. Solotar, Ph.D., ABPP, “we believe that promoting awareness about autism is as important as ever. It is my hope that this pandemic will make us all more aware of and empathetic toward not only the needs of individuals with autism, but of the needs of all of the most vulnerable individuals in our community and around the world.”

The National Autism Center at May Institute continues to offer free, downloadable resources about autism treatments at www.nationalautismcenter.org, including information about early warning signs.

About May Institute
May Institute is a nonprofit organization that is a national leader in the field of applied behavior analysis, serving individuals with ASD and other developmental disabilities, brain injury and neurobehavioral disorders, and other special needs. Founded 65 years ago, we provide a wide range of exceptional educational and rehabilitative services across the lifespan.

May’s National Autism Center is dedicated to disseminating evidence-based information about the treatment of ASD, promoting best practices, and offering comprehensive and reliable resources for families, practitioners, and communities. For more information, call 800.778.7601 or visit www.mayinstitute.org.

 
Facebook Twitter LinekdIn YouTube Flickr Issuu

 

May Institute does not discriminate on the basis of race, color, religion, ancestry, national origin, age, physical or mental disability, sex/gender, gender identity, sexual orientation, military status, veteran status, genetic information, pregnancy, pregnancy-related conditions, marital status, socioeconomic status, homelessness, or any other category protected under applicable law in treatment or employment at the Institute, admission or access to the Institute, or any other aspect of the educational programs and activities that the Institute operates. The Institute is required by Title VI of the Civil Rights Act of 1964 (Title VI), Section 504 of the Rehabilitation Act of 1973 (Section 504), Title IX of the Education Amendments of 1972 (Title IX), the Age Discrimination Act of 1975 (Age Act), and their respective implementing regulations at 34 C.F.R. Parts 100, 104, 106 and 110, not to discriminate on the basis of race, color, or national origin (Title VI); disability (Section 504); sex (Title IX); or age (Age Act). Inquiries concerning the application of each of these statutes and their implementing regulations to the Institute may be referred to the U.S. Department of Education, Office for Civil Rights, at (617) 289-0111 or 5 Post Office Square, 8th Floor, Boston, MA 02109-3921, or to Pamela Raymond, Title IX Coordinator at 1.800.437.1200  ext.1252 or compliance@mayinstitute.org or May Institute 14 Pacella Park Drive, Randolph, MA 02368.